PBYI
Puma Biotechnology Inc
NASDAQ: PBYI · HEALTHCARE · BIOTECHNOLOGY
$7.48
-0.80% today
Updated 2026-04-29
Market cap
$382.08M
P/E ratio
12.31
P/S ratio
1.67x
EPS (TTM)
$0.61
Dividend yield
—
52W range
$3 – $8
Volume
0.4M
WallStSmart proprietary scores
71
out of 100
Grade: B
Buy
Investment rating
4.7
Growth
C5.0
Quality
C+8.0
Profitability
A9.3
Valuation
A+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$5.00
-33.16%
12-Month target
$4.87
-34.89%
Intrinsic (DCF)
$28.43
Margin of safety
+76.64%
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ ROE 28.00% — strong efficiency
+ Free cash flow $14.38M — positive
+ Revenue growth 27.70% QoQ
+ 76.64% below intrinsic value
Risks
No major risks identified
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $228.03M | $235.64M | $230.47M | $228.37M | $228.37M |
| Net income | $2000.00 | $21.59M | $30.28M | $31.11M | $13.40M |
| EPS | — | — | — | — | $0.61 |
| Free cash flow | $-22.83M | $14.37M | $38.86M | $41.73M | $14.38M |
| Profit margin | 0.00% | 9.16% | 13.14% | 13.62% | 13.60% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-02-18 | NOUGUES, MAXIMO F | Buy | 66,541 | — |
| 2026-02-18 | NOUGUES, MAXIMO F | Buy | 46,739 | — |
| 2026-02-18 | HUNT, DOUGLAS M | Buy | 70,321 | — |
Peer comparison
Smart narrative
Puma Biotechnology Inc trades at $7.48. representing a P/E of 12.31x trailing earnings. Our Smart Value Score of 71/100 indicates the stock is good. TTM revenue stands at $228.37M. with profit margins at 13.60%. Our DCF model estimates intrinsic value at $28.43.
Frequently asked questions
What is Puma Biotechnology Inc's stock price?
Puma Biotechnology Inc (PBYI) trades at $7.48.
Is Puma Biotechnology Inc overvalued?
Smart Value Score 71/100 (Grade B, Buy). DCF value $28.43.
What is the price target of Puma Biotechnology Inc (PBYI)?
The analyst target price is $5.00, representing -33.2% downside from the current price of $7.48.
What is the intrinsic value of Puma Biotechnology Inc (PBYI)?
Based on our DCF model, intrinsic value is $28.43, a +76.6% margin of safety versus $7.48.
What is Puma Biotechnology Inc's revenue?
TTM revenue is $228.37M.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.67x
ROE28.00%
Beta1.18
50D MA$6.75
200D MA$5.56
Shares out0.05B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week-1.32%
1 month+22.06%
3 months+17.27%
YTD+25.55%
1 year—
3 years—
5 years—